Tweenvest Stocks

ETFis Series Trust I - Virtus Biotech Clinical Trials ETF (ARCA: BBC)

Financials · Capital Markets · US

$52.87

+0.67% today · +132.0% 1Y

ETFis Series Trust I - Virtus Biotech Clinical Trials ETF (ARCA: BBC) operates in the Capital Markets industry within the Financials sector. The company is valued at $50.22M.

Over the last twelve months the share price has gained 132.0%, trading between 20.87 and 54.95.

Tweenvest scores ETFis Series Trust I - Virtus Biotech Clinical Trials ETF across four factors: dividend 28/100. Its strongest factor is dividend.

BBC price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$50.22M
Revenue (TTM)
P/E
EPS
Dividend yield
1.24%
Beta (5Y)
0.88
52-week high
$54.95
52-week low
$20.87
Avg volume (3M)
Shares outstanding
950.00K
Employees
Next earnings

About ETFis Series Trust I - Virtus Biotech Clinical Trials ETF

This exchange-traded fund (ETF) endeavors to match the capital appreciation and income generation of the LifeSci Biotechnology Clinical Trials Index, disregarding fees and expenses. The underlying index focuses on tracking the financial progress of a carefully chosen group of biotechnology firms engaged in clinical trials. It is important to note that, as of February 27, the fund's official name transitioned from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.

ISIN
US26923G3011
Founded
2014
Listed since
Dec 17, 2014
Exchange
NYSE Arca
Currency
USD
CompanyMarket capPriceDay
Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETFARCA: VTI$2.31T$378.24+0.44%
Vanguard Index Funds - Vanguard S&P 500 ETFARCA: VOO$1.66T$703.71+0.39%
iShares Trust - iShares Core S&P 500 ETFARCA: IVV$893.67B$769.31+0.39%
State Street SPDR S&P 500 ETF TrustARCA: SPY$821.60B$765.72+0.41%
Invesco QQQ Trust, Series 1NasdaqGM: QQQ$487.14B$713.44+0.36%
Vanguard Index Funds - Vanguard Morningstar Growth ETFARCA: VUG$378.44B$87.50+0.38%
Morgan StanleyNYSE: MS$336.42B$214.20+3.25%
The Goldman Sachs Group, Inc.NYSE: GS$314.66B$1,039.28+3.73%

Browse every Capital Markets company →

Figures last refreshed Aug 18, 2026.